Drug
Traditional Vitamin D Therapy
Traditional Vitamin D Therapy: highest development phase Post-Market, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Traditional Vitamin D Therapy NCT01181531 | Post-Market | Hyperparathyroidism, Secondary |
Latest
No recent events.
Follow Traditional Vitamin D Therapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.